Proton therapy safer than older radiotherapies for esophageal cancer

the ONA take:

According to new researcher presented at the annual conference of the Particle Therapy Cooperative Group in San Diego, California, researchers from the University of Maryland School of Medicine in Baltimore have found that patients with esophageal cancer treated with proton therapy experienced significantly fewer adverse events than patients treated with conventional radiation therapies.

For the study, researchers identified about 600 patients with esophageal cancer and found that proton therapy was associated with significantly fewer incidents of nausea, blood abnormalities, and loss of appetite than older radiation therapies.

Proton therapy has shown efficacy in various types of cancer, including brain, breast, esophageal, head and neck, liver, lung, prostate, and spinal cord cancers. It is expected that up to 30% of patients with cancer will benefit from targeted proton beam therapy, which can precisely target tumors while reducing radiation to healthy issue.

"This evidence underscores the precision of proton therapy, and how it can really make a difference in cancer patients' lives," said Michael Chuong, MD, an assistant professor of radiation oncology at the University of Maryland School of Medicine.

Gefitinib may be effective to treat esophageal cancer in some patients
Patients with esophageal cancer treated with proton therapy experienced significantly fewer adverse events.
New research by scientists at the University of Maryland School of Medicine has found that esophageal cancer patients treated with proton therapy experienced significantly less toxic side effects than patients treated with older radiation therapies.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs